Question 1: Discuss the MOA of cholinesterase inhibitors, NMDA antagonists, and the implications for treating Dementia.
Question 2: Describe psychopharmacological intervention for treating the behavioral symptoms of dementia.
Question 3: Discuss the pertinent monitoring and safety factors.